Health Tech Invest’s Post

So proud Kaydee M. works at a great company.

What if we could generate novel protein therapeutics using new computational tools, without having to discover them through trial and error? That’s what we at Flagship Pioneering asked ourselves in founding Generate:Biomedicines. With new, computationally-derived medicines now advancing in the clinic, the answer is clear: we can revolutionize drug development.

Look Dr. Ruth Gross up! I assure you will have an interesting and insightful conversation on our innovative AI driven computational platforms. #israelinnovation #evogen #decodingbiology

AI and cloud technology are driving a revolution in healthcare, offering unprecedented opportunities to combat cancer and rare diseases. SOPHiA GENETICS is at the forefront with its transformative platform, SOPHiA DDM™, enabling faster, data-driven decisions for researchers and healthcare professionals worldwide. I’m thrilled to share how we partnered with SOPHiA GENETICS to support their global user base and optimize their technology infrastructure. Whether it was streamlining processes, enhancing tools like JIRA, or clearing backlogs, our agile-minded team was there every step of the way. What excites me the most? Seeing how these innovations accelerate diagnostics and improve patient care. It’s a privilege to be part of a journey shaping healthcare’s future. 🙌 More details: https://okt.to/gRPlc3 Let’s talk! What role do you see technology playing in precision medicine? #AIInHealthcare #PartnershipsForImpact #HealthcareInnovation

@Machine Learning, Artificial Intelligence, Deep Learning, Computer Vision, Robotics, Python, Gen AI

AI NEWS SERIES Atropos Health Platform with AI Capabilities Secures $33M Product: - Atropos Health utilizes Geneva OS™, a clinical analytics platform that structures medical data for rapid real-world evidence generation, capable of transforming data analysis from months to minutes. - Features include ChatRWD™, which provides AI-powered, chat-to-database evidence generation, and the Green Button Informatics Consult Service, enabling quick access to observational studies and evidence. Company: - Founded in 2020 and based in Palo Alto, California, Atropos Health has raised $47M in funding from investors including Sanofi Ventures and Breyer Capital, focusing on evidence-based healthcare solutions. Impact: - Atropos Health's technologies streamline the creation of personalized medical evidence, enhancing decision-making in healthcare and accelerating drug development. This advancement supports a more efficient healthcare system with faster and more effective patient care strategies. sources: businesswire #technology #innovation #future #artificialintelligence #business

🤔 Have you explored TrialPioneer™️ yet? Our intuitive, free tool leverages extensive datasets from actual patient populations to enable quick comparisons between traditional vs AI-powered trial designs. #TrialPioneer offers insights that can significantly reduce trial timelines and costs, ensuring that groundbreaking treatments reach patients sooner. 🚀 Explore the possibilities today: https://lnkd.in/gXYN-nZ3

TODAY at the Thinc Value-Based Care Conference, don’t miss this insightful session on value-based care, featuring Todd Newby from USRenal Care alongside other industry leaders! 📅 1:30pm ET - Leveraging Emerging Technologies and Analytic Tools in Managing Complex Chronic Conditions (Corning) Speakers: Joseph (Joe) Smith, MD, PhD & Todd Newby, US Renal Be sure to stop by our table to connect with the PulseData AI team and learn more about how our AI and ML solutions are transforming chronic condition management. Let’s explore the future of value-based care together! #Healthcare #VBC #EmergingTechnologies #AI #ML #Analytics #thINcValue #thINcVBC

Advanta Genetics is transforming healthcare - and here's how. By delivering spot-on, fast diagnostics, we're making patient care better and more efficient. It's not just about the tech; it's about how we use it to make real differences in people's lives. This is where science meets compassion. #HealthcareInnovation #PCRRevolution #PatientCareFirst Image: 🤖📸🔧: AI-made image w/ human-edits

Last week Miruna Sasu and panelists discussed whether pharma companies should build or buy data science capabilities at the #BioITExpo in Boston. The conversation naturally shifted to AI and the consensus from the group: If you're going to outsource your AI build, leave it to the experts. As an industry, we have to improve data quality and access - while maintaining privacy and security - and the stakes couldn't be higher. Thanks to all participants for this important and timely discussion. Mika Newton, CEO, xCures Dana Callow, Founder & Managing Partner, Boston Millennia Partners Tom Neyarapally, CEO and Co-Founder, Archetype Therapeutics, Inc. Miruna Sasu, President and CEO, COTA Xiaoying Wu, MD,MS Wu, MD, MS, Vice President, Data Science & Digital Health, Janssen Inc.